Huntington National Bank’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3 | Hold |
1
| – | – | ﹤0.01% | 3943 |
|
|
2025
Q1 | $3 | Hold |
1
| – | – | ﹤0.01% | 3953 |
|
|
2024
Q4 | $3 | Hold |
1
| – | – | ﹤0.01% | 3959 |
|
|
2024
Q3 | $3 | Hold |
1
| – | – | ﹤0.01% | 3950 |
|
|
2024
Q2 | $3 | Hold |
1
| – | – | ﹤0.01% | 3901 |
|
|
2024
Q1 | $3 | Hold |
1
| – | – | ﹤0.01% | 3774 |
|
|
2023
Q4 | $3 | Hold |
1
| – | – | ﹤0.01% | 3673 |
|
|
2023
Q3 | $3 | Hold |
1
| – | – | ﹤0.01% | 3650 |
|
|
2023
Q2 | $3 | Hold |
1
| – | – | ﹤0.01% | 3598 |
|
|
2023
Q1 | $3 | Hold |
1
| – | – | ﹤0.01% | 3470 |
|
|
2022
Q4 | $3 | Hold |
1
| – | – | ﹤0.01% | 3334 |
|
|
2022
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 2839 |
|
|
2022
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 2821 |
|
|
2022
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 2736 |
|
|
2021
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 2638 |
|
|
2021
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 2364 |
|
|
2021
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 2257 |
|
|
2021
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 2159 |
|
|
2020
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 2136 |
|
|
2020
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 2081 |
|
|
2020
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 2109 |
|
|
2020
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 2187 |
|
|
2019
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 2179 |
|
|
2019
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 2104 |
|
|
2019
Q2 | $0 | Buy |
+1
| New | – | ﹤0.01% | 2136 |
|
|
2019
Q1 | – | Sell |
-1
| Closed | – | – | 2109 |
|
|
2018
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 2146 |
|
|
2018
Q3 | $0 | Buy |
+1
| New | – | ﹤0.01% | 2119 |
|